Skip to main content
SpringerLink
Log in

Hypertension in the Diabetic Patient

Selection and Optimum Use of Antihypertensive Drugs

  • Practical Therapeutics
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Understanding of the pathophysiology of hypertension and diabetes mellitus and their association is at present fragmentary at best. Optimal antihypertensive drug therapy of patients with both disorders is therefore based on limited experimental data, practical experience and educated guesswork, and needs to be tailored to each (often multimorbid) individual.

In most patients monotherapy would be preferred, and would begin with a calcium antagonist or a converting enzyme inhibitor at a low to moderate dosage. If this is not effective an α1- adrenoceptor inhibitor, a cardioselective β-blocker or a diuretic, always at a low to moderate dosage, should be tried. If still unsuccessful, low dose combinations of 2 of these drugs are next. The (long term) regimen should be as simple as possible, and its effects — desired and undesired — monitored as closely as the carbohydrate disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amery A, Berthaux P, Bulpitt C, Deruyttere M, De Schaepdryver A, et al. Glucose intolerance during diuretic therapy. Lancet 1: 681–683, 1978

    Article  PubMed  CAS  Google Scholar 

  • Ames RP. Metabolic disturbances increasing the risk of coronary heart disease during diuretic-based antihypertensive therapy: lipid alterations and glucose intolerance. American Heart Journal 106: 1207–1215, 1983

    Article  PubMed  CAS  Google Scholar 

  • Barbieri C, Ferrari C, Borzio M, Piepoli V, Caldara R. Metabolic effects of chronic prazosin treatment. Hormone and Metabolic Research 12: 331–334, 1980

    Article  PubMed  CAS  Google Scholar 

  • Barnett AH, Leslie D, Watkius PJ. Can insulin-treated diabetics be given beta-adrenergic blocking drugs? British Medical Journal 280: 976–978, 1980

    Article  PubMed  CAS  Google Scholar 

  • Benfield GFA, Hunter KR. Oxprenolol, methyldopa and lipids in diabetes mellitus. British Journal of Clinical Pharmacology 13: 219–222, 1982

    Article  PubMed  CAS  Google Scholar 

  • Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. British Medical Journal 293: 471–474, 1986

    Article  PubMed  Google Scholar 

  • Chazan BI, Old JM, Venkataraman G, Snape J, Cameron EGM. A beta blocker-thiazide combination in the treatment of hypertension in diabetics. British Journal of Clinical Practice 35: 393–398, 1981

    PubMed  CAS  Google Scholar 

  • Christlieb AR, Maki PC. The effect of beta-blocker therapy on glucose and lipid metabolism. Primary Cardiology (Suppl.): 47–54, 1980

  • Corcoran JS, Perkins JE, Hoffbrand BI, Yudkin JS. Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide. Diabetic Medicine 4: 164–168, 1987

    Article  PubMed  CAS  Google Scholar 

  • Coves MJ, Gomis R, Goday A, Casamitjana R, Rivera F, et al. Tratamiento hipotensor con guanfacina en pacientes afectos de diabetes mellitus tipo II. Medicina Clinica (Barcelona) 88: 315–317, 1987

    CAS  Google Scholar 

  • D’Angelo A, Giannini S, Benetollo P, Castrignano R, Lodetti MG, et al. Efficacy of captopril in hypertensive diabetic patients. American Journal of Medicine 84 (Suppl. 3A): 155–158, 1988

    Article  PubMed  Google Scholar 

  • Deacon SP, Karunanayake A, Barnett D. Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. British Medical Journal 2: 1255–1257, 1977

    Article  PubMed  CAS  Google Scholar 

  • De Châtel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, et al. Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney International 12: 412–421, 1977

    Article  PubMed  Google Scholar 

  • Dodson PM, Pacy PJ, Bai P, Kubicki AJ, Fletcher RF, et al. A controlled trial of a high fibre, low fat and low sodium diet for mild hypertension in type 2 (non-insulin-dependent) diabetic patients’ Diabetologia 27: 522–526, 1984

    Article  PubMed  CAS  Google Scholar 

  • Dominguez JR, De La Calle H, Hurtado A, Robles RG, SanchoRof J. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus. Postgraduate Medical Journal 62 (Suppl. 1): 66–68, 1986

    PubMed  Google Scholar 

  • Dornhorst A, Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1: 123–126, 1985

    Article  PubMed  CAS  Google Scholar 

  • Dvorak I, Podrouzkova B, Kocourkova J, Kubesova H, Spac J, et al. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus. Cor et Vasa 29: S30–S36, 1987

    Google Scholar 

  • Escobar-Jiminez F, Soto MLF, Lobon JA, Aguilar M, Campos-Pastor MM, et al. Effect of captopril at 2 different dosage regimens in hypertensive non-insulin dependent patients. Postgraduate Medical Journal 64 (Suppl. 3): 65–68, 1988

    PubMed  Google Scholar 

  • Eto M, Watanabe K, Otake Y, Morikawa A, Takebe T, et al. Effects of captopril on blood pressure, metabolic control, plasma lipids, and proteinuria in elderly hypertensive diabetics. Current Therapeutic Research 43: 427–434, 1988

    Google Scholar 

  • Ferlito S, Indelicato G, Di Vincenzo S, Del Campo F, La Vignera A, et al. Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics. Journal of Endocrinological Investigation 8: 185–187, 1985

    PubMed  CAS  Google Scholar 

  • Ferlito S, Puleo F, Carra G, Damante G, Di Vincenzo S, et al. Effect of alpha-1-blockade by prazosin on blood sugar, insulin and glucagon levels in normals and non-insulin dependent diabetics. Journal of Endocrinological Investigation 6: 199–202, 1983

    PubMed  CAS  Google Scholar 

  • Ferrière M, Lachkar H, Richard JL, Bringer J, Orsetti A, et al. Captopril and insulin sensitivity. Annals of Internal Medicine 102: 134–135, 1985

    PubMed  Google Scholar 

  • Fetkovska N, Brimichova G, Sebekova K, Dzurik R. Long-term clinical experience with guanfacine. Cor et Vasa 29: S23–S29, 1987

    Google Scholar 

  • Fonseca V, Phear DN. Hyperosmolar non-ketotic diabetic syndrome precipitated by treatment with diuretics. British Medical Journal 284: 36–37, 1982

    Article  PubMed  CAS  Google Scholar 

  • Garrett BN, Raskin P, Kaplan NM. Metoprolol in diabetes mellitus: effect on glucose homeostasis. Clinical Science 59: 469S–472S, 1980

    PubMed  CAS  Google Scholar 

  • Gentile S, Coltorti M. Hypotensive effect of the association atenolol-chlorthalidone in hypertensive diabetics. Journal of International Medical Research 12: 281–285, 1984

    PubMed  CAS  Google Scholar 

  • Gill JS, Al-Hussary N, Atkins TW, Taylor KG, Beevers DG. Possible role for insulin receptors in the mechanism of thiazide induced glucose tolerance. Journal of Hypertension 2: S573–S576, 1984

    Article  PubMed  CAS  Google Scholar 

  • Goldner MG, Zarowitz H, Akgun S. Hyperglycemia and glycosuria due to thiazide derivatives administered in diabetes mellitus. New England Journal of Medicine 262: 403–405, 1960

    Article  PubMed  CAS  Google Scholar 

  • Groop L, Töttermann KJ. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus. Acta Endocrinologica 100: 410–415, 1982

    PubMed  CAS  Google Scholar 

  • Groop L, Töttermann KJ, Harno K, Gordin A. Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Acta Medica Scandinavica 211: 7–12, 1982

    Article  PubMed  CAS  Google Scholar 

  • Grunfield C, Chappell DA. Hypokalemia and diabetes mellitus. American Journal of Medicine 75: 553–554, 1983

    Article  Google Scholar 

  • Gundersen T, Kjekshus J. Timolol treatment after myocardial infarction in diabetic patients. Diabetes Care 6: 285–290, 1983

    Article  PubMed  CAS  Google Scholar 

  • Guthrie GP, Miller RE, Kotchen TA, Koenig SK Clonidine in patients with diabetes and mild hypertension. Clinical Pharmacology and Therapeutics 34: 713–717, 1983

    Article  PubMed  Google Scholar 

  • Gutin M, Tuck ML. Metabolic control during guanabenz anti-hypertensive therapy in diabetic patients with hypertension. Current Therapeutic Research 43: 775–785, 1988

    CAS  Google Scholar 

  • Hauger-Klevene JH, Scornavacchi JC. Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine for one year. European Journal of Clinical Pharmacology 29: 391–393, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hay U, Ludvik B, Gisinger C, Schernthaner G. Fehlender Effekt der ACE-Inhibition auf die Makroproteinurie bei diabetischer Nephropathie: eine Langzeitstudie über 6 Monate. Schweizerische Medizinische Wochenschrift 118: 165–169, 1988

    PubMed  CAS  Google Scholar 

  • Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111, 1983

    Article  PubMed  CAS  Google Scholar 

  • Holm G, Johansson S, Vedin A, Wilhelmsson C, Smith U. The effect of beta-blockade on glucose tolerance and insulin release in adult diabetes. Acta Medica Scandinavica 208: 187–191, 1980

    Article  PubMed  CAS  Google Scholar 

  • Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielsen MD, et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. British Medical Journal 293: 467–470, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. New England Journal of Medicine 308: 373–376, 1983

    Article  PubMed  CAS  Google Scholar 

  • Janka HU, Standl R, Vollmar J, Bauer G, Mehnert H. Der Einfluss einer antihypertensiven Kombinationstherapie auf den Stoffwechsel von Diabetikern. Therapie der Gegenwart 119: 74–89, 1980

    PubMed  CAS  Google Scholar 

  • Kannel WB. Hypertension: relationship with other risk factors. Drugs 31 (Suppl. 1): 1–11, 1986

    Article  PubMed  Google Scholar 

  • Kindermann W, Lehrmann S, Schmitt W. Körperliche Leistungsfähigkeit und Metabolismus. Einfluss einer Kombination von Nifedipin und Mefrusid. Münchener Medizinische Wochenschrift 128: 53–56, 1986a

    Google Scholar 

  • Kindermann W, Schmitt W, Wolfing A, Körperliche Leistungsfähigkeit, Metabolismus und hormonelles Verhalten unter Diltiazem. Zeitschrift für Kardiologie 75: 99–106, 1986b

    PubMed  CAS  Google Scholar 

  • Kolendorf K, Bonnevie-Nielsen V, Broch-Møller B. A trial of metoprolol in hypertensive insulin-dependent diabetic patients. Acta Medico Scandinavica 211: 175–178, 1982

    Article  CAS  Google Scholar 

  • Königstein RP. Die Behandlung der Hypertonie mit Prazosin bei ‘Altersdiabetikern’. Wiener Medizinische Wochenschrift (Suppl. 1): 27–30, 1978

  • Kwan CM, Shepherd AMM, Johnson J, Taylor WF. Forearm and finger hemodynamics, blood pressure control:, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin. Clinical Pharmacology and Therapeutics 44: 202–210, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lager I, Blohmé G, Smith U. Effect of cardioselective and non-selective β-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet 1: 458–462, 1979

    Article  PubMed  CAS  Google Scholar 

  • Lanza G, Barbera R, Fontana S. Trattamento dell’ipertensione nel diabetico con Captopril. Minerva Medica 76: 183–184, 1985

    PubMed  CAS  Google Scholar 

  • Lanza G, Barbera R, Travaglino F, Fontana S. Trattamento prolungato dell’ipertensione nel diabetico con Enalapril. Minerva Medica 78: 1601–1606, 1987

    PubMed  CAS  Google Scholar 

  • Leichter SB, Baumgardner B. Effects of chronic prazosin therapy on intermediary metabolism in diabetic patients. Journal of Cardiovascular Medicine (Suppl.): 38–42, 1981

  • Lipson LG. Treatment of hypertension in diabetic men: problems with sexual dysfunction. American Journal of Cardiology 53: 46A-50A, 1984

    Article  Google Scholar 

  • Matthews DM, Collier DA, Clarke BF, Wathen CH, Bell D, et al. The role of captopril in the treatment of hypertension in non-insulin dependent diabetes. Postgraduate Medical Journal 62 (Suppl. 1): 73–75, 1986

    PubMed  Google Scholar 

  • Micossi P, Pollavini G, Raggi U, Librenti MC, Garimberti B, et al. Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus. Hormone and Metabolic Research 16: 59–63, 1984

    Article  PubMed  CAS  Google Scholar 

  • Mpoy M, Vandeleene B, Ketelslegers JM, Lambert AE. Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmetidine. American Journal of Cardiology 61 (Suppl. D): 91D–94D, 1988

    Article  PubMed  CAS  Google Scholar 

  • Murphy MB, Lewis PJ, Kohner E, Schumer B, Dollery CT. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet 2: 1293–1295, 1982

    Article  PubMed  CAS  Google Scholar 

  • Nilsson-Ehle P, Ekberg M, Fridström P, Ursing D, Lins LE. Lipo-proteins and metabolic control in hypertensive type II diabetics treated with clonidine. Acta Medica Scandinavica 224: 131–134, 1988

    Article  PubMed  CAS  Google Scholar 

  • Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, et al. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. British Medical Journal 294: 1443–1447, 1987

    Article  PubMed  CAS  Google Scholar 

  • Passa P, LeBlanc H, Gauvillé C, Tabuteau F, Canivet J. Effets de la clonidine administrée au long cours sur la sécrétion d’hormone de croissance chez le diabétique hypertendu. Diabète et Métabolisme 8: 295–298, 1982

    PubMed  CAS  Google Scholar 

  • Passa P, LeBlanc H, Marre M. Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 10: 200–204, 1987

    Article  PubMed  CAS  Google Scholar 

  • Podolsky S, Pattavina CG. Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. Metabolism 22: 685–693, 1973

    Article  PubMed  CAS  Google Scholar 

  • Popp DA, Tse TF, Shah SD, Clutter WE, Cryer PE. Oral propranolol and metoprolol both impair glucose recovery from insulin-induced hypoglycemia in insulin-dependent diabetes mellitus. Diabetes Cafe 7: 243–247, 1984

    Article  CAS  Google Scholar 

  • Rendell M, Lassek WD, Ross DA, Smith C, Kernek S, et al. A pharmaceutical profile of diabetic patients. Journal of Chronic Diseases 36: 193–202, 1983

    Article  PubMed  CAS  Google Scholar 

  • Rett K, Lotz N, Wicklmayr M, Fink E, Jauch KW, et al. Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ II-Diabetiker. Deutsche Medizinische Wochenschrift 113: 243–249, 1988a

    Article  PubMed  CAS  Google Scholar 

  • Rett K, Wicklmayr M, Tschollar W; Dietze G, Mehnert H. Role of angiotensin-converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus. Postgraduate Medical Journal 64 (Suppl. 3): 69–73, 1988b

    PubMed  Google Scholar 

  • Ricci PD, Fazzi K, Ricci F. Il captopril nel controllo dell’ipertensione arteriosa essenziale dell soggetto diabetico. Clinica Terapeutica 113: 33–38, 1985

    PubMed  CAS  Google Scholar 

  • Riobo P, Garcia-Robles R, Estopinan V, Hurtado A, Sancho-Rof J. Effect of long-term inhibition of converting enzyme on carbohydrate metabolism in non-insulin dependent diabetic patients with essential hypertension. Abstract. Postgraduate Medical Journal 64 (Suppl. 3): 63–64, 1988

    Google Scholar 

  • Rowe PA, Mather HG. Hyperosmolar non-ketotic diabetes mellitus associated with metolazone. British Medical Journal 291: 25–26, 1985

    Article  PubMed  CAS  Google Scholar 

  • Ryan JR, LaCorte W, Jain A, McMahon FG. Hypertension in hypoglycemic diabetics treated with β-adrenergic antagonists. Hypertension 7: 443–446, 1985

    PubMed  CAS  Google Scholar 

  • Shapiro AP, Benedek TG, Small JL. Effect of thiazides on carbohydrate metabolism in patients with hypertension. New England Journal of Medicine 265: 1028–1033, 1961

    Article  Google Scholar 

  • Shionoiri H, lino S, Inoue S. Glucose metabolism during captopril mono- and combination therapy in diabetic hypertensive patients: a multiclinic trial. Clinical and Experimental Hypertension-Theory and Practice 9(2-3): 671–674, 1987

    Article  CAS  Google Scholar 

  • Shionoiri H, Noda K, Miyamoto K, Hiroto S, Umemura S, et al. Glucose tolerance during chronic prazosin therapy in patients with essential hypertension. Current Therapeutic Research 40: 171–180, 1986

    Google Scholar 

  • Sood VP, Stannard M, Beastall G, Weir RJ. Indoramin in the hypertensive diabetic patient. Journal of Cardiovascular Pharmacology 8: S80–S83, 1986

    Article  PubMed  Google Scholar 

  • Stevenson JG, Umstead GS. Sexual dysfunction due to anti-hypertensive agents. Drug Intelligence and Clinical Pharmacy 18: 113–121, 1984

    PubMed  CAS  Google Scholar 

  • Stornello M, Di Rao G, Iachello M, Bosco V, Pantano S, et al. Valutazione clinica del trattamento antiipertensivo con alfa-metildopa di pazienti affetti da ipertensione arteriosa e diabète mellito. Clinica Terapeutica 101: 257–265, 1982

    PubMed  CAS  Google Scholar 

  • Sullivan PA, Kelleher M, Twomey M, Dineen M. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. Journal of Hypertension 3: 359–363, 1985

    Article  PubMed  CAS  Google Scholar 

  • Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, et al. Effect of captopril on heavy proteinuria in azotemic diabetics. New England Journal of Medicine 313: 1617–1620, 1985

    Article  PubMed  CAS  Google Scholar 

  • Trost BN, Weidmann P. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. Journal of Hypertension 5: S81–S104, 1987

    Article  PubMed  CAS  Google Scholar 

  • Trost BN, Weidmann P. Five years of antihypertensive mono-therapy with nitrendipine do not alter carbohydrate homeostasis in diabetic patients. Abstract. Journal of Cardiovascular Pharmacology 12 (Suppl. 6): S184, 1988a

    Article  Google Scholar 

  • Trost BN, Weidmann P. Metabolic effects of calcium antagonists in man, with emphasis on carbohydrate, lipid, potassium and uric acid homeostases. Journal of Cardiovascular Pharmacology 12 (Suppl. 6): S86–S92, 1988b

    Article  PubMed  Google Scholar 

  • Trost BN, Weidmann P, Riesen W, Claessen J, Streulens Y, et al. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension. American Journal of Cardiology 59: 99G-104G, 1987

    Article  Google Scholar 

  • Valvo E, Bedogna V, Casagrande P, Antiga L, Zamboni M, et al. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. American Journal of Medicine 85: 344–348, 1988

    Article  PubMed  CAS  Google Scholar 

  • Vardan S, Mehrotra KG, Mookherjee S, Willsey G A, Gens JD, et al. Efficacy and reduced metabolic side effects of a 15mg chlorthalidone formulation in the treatment of mild hypertension. Journal of the American Medical Association 258: 484–488, 1987

    Article  PubMed  CAS  Google Scholar 

  • Vidt DG, Bravo EL, Fouad FM. Captopril. New England Journal of Medicine 306: 214–219, 1982

    Article  PubMed  CAS  Google Scholar 

  • Wallin JD, Krane NK, Bergman S, Morgan M. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and. mild hypertension. Journal of Clinical Hypertension 4: 315–321, 1985

    Google Scholar 

  • Warren SE. False-positive urine ketone test with captopril. New England Journal of Medicine 303: 1003–1004, 1980

    PubMed  CAS  Google Scholar 

  • Weber MA, Drayer JIM, Deitch MW. Hypertension in patients with diabetes mellitus; treatment with a centrally acting agent. Journal of Cardiovascular Pharmacology 6: S823–S829, 1984

    Article  PubMed  Google Scholar 

  • Weidmann P, Beretta-Piccoli C, Keusch G, Glück Z, Mujagic M, et al. Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. American Journal of Medicine 67: 779–784, 1979

    Article  PubMed  CAS  Google Scholar 

  • Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins. Journal of Hypertension 3: 297–306, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wilson PWF, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly: the Framingham study. American Journal of Medicine 80 (Suppl. 5A): 3–9, 1986

    Article  PubMed  CAS  Google Scholar 

  • Winocour P, Waldek S, Anderson DC. Captopril and blood glucose. Lancet 2: 461, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Winocour P, Waldek S, Johns CW, Dhar H, Anderson DC. Captopril may adversely affect renal function in hypertensive diabetics without established nephropathy. Journal of Endocrinology 108 (Suppl.): 216, 1986b

    Google Scholar 

  • Wright AD, Barber SG, Kendall MJ, Poole PH. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. British Medical Journal 1: 159–161, 1979

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitätspoliklinik, Inselspital, CH-3010, Bern, Switzerland

    Bernhard N. Trost

Authors
  1. Bernhard N. Trost
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trost, B.N. Hypertension in the Diabetic Patient. Drugs 38, 621–633 (1989). https://doi.org/10.2165/00003495-198938040-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198938040-00008

Keywords

Search

Navigation